معرفی
Dr. Sandra Goetze is a Lecturer at the Department of Biology at ETH Zürich, affiliated with the Proteomics Platform D-HEST. Her research focuses on proteomics, multi-omics integration, and translational applications in cancer and metabolic disorders. She specializes in developing precision medicine tools through functional genomics, proteogenomics, and systems biology approaches. Her work bridges clinical diagnostics and drug discovery, particularly in glioblastoma, melanoma, and myeloid malignancies.
Key research interests include:
- Multi-omics profiling for disease mechanism decoding
- Drug repurposing strategies using functional tissue profiling
- HDL structure-function relationships in cardiovascular health
- Standardization of mass cytometry and proteotyping techniques
Her publications (2020–2025) highlight advancements in single-cell analysis, biomarker discovery, and clinical decision-making frameworks. She collaborates internationally on projects like the SwissPedHealth network and the Tumor Profiler Study.
Dr. Goetze's work emphasizes translational impact, with a focus on leveraging omics data for personalized therapeutic strategies. Current projects include ex vivo drug response modeling and proteogenetic vulnerability mapping in hematologic cancers.
